Agno Pharma is a global pharmaceutical contract research and manufacturing organization (CRO & CMO), with a US-FDA approved, ISO 9001, ISO 14001, & OHSAS 18001 certified GMP API manufacturing facility in China. We engage in the research, development, manufacturing, sourcing, marketing, and distribution of chemically and biologically derived pharmaceutical intermediates, APIs, nutraceuticals, and fine chemicals. Agno Pharma is a leading CRO/CMO, providing a broad range of high-quality, integrated services across both drug discovery and drug development.
We are a fully integrated company with in-house business development, R&D, manufacturing and regulatory compliance capabilities. Our company is founded upon our belief in the synergistic merger of ICH pharmaceutical technologies, management, product registration, and cGMP compliance, together with China's cost-effective research, development, and manufacturing capabilities.